Replies to post #50636 on RedHawk Holdings Corp (fka SNDD)

[Divest]

Thanks for that unusual interpretation of what is going on here. Now let me direct your attention to some real numbers. From the 1st quarter filing we know two things:

Disaggregation of Revenue

For the quarters ended September 30, 2019 and 2018, a summary of our revenue on a disaggregated basis is as follows:



Sales of medical devices
2019 2018
40,808 195

pg. 12 Disaggregation of Revenue

Gross profit margin from the sale of the Company’s needle incineration devices approximated 80% during the quarter ended September 30, 2019 as compared to only 27% from sales of the Company’s branded generic pharmaceuticals in the comparable quarter ended September 30, 2018.

pg. 24 Under Operating revenue subtitle.

The next question is how many units did they sell? Thankfully we have an old pr that staes 250 sold at a discount, you can read it here: http://ih.advfn.com/stock-market/USOTC/redhawk-holdings-corp-SNDD/stock-news/80893730/redhawk-completes-a-limited-marketing-campaign-and

Now for a little basic math $40,808 divided by 250 equals $163.23 per sale. 80% of which was profit that yields a cost per unit of $36.64. Now that we have factual filing based numbers to work with it is obvious that the company is not losing money by selling units for $179.99.